Company Data
MeiraGTx Holdings plc
Ticker
MGTX
Current Price
$7.42 -3.51%
Market Cap
$597.2M
Price Target
Refer to Report
Volume
745.7K
52wk Range
$4.55 - $9.73
Overview
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company’s pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union.